Annual report pursuant to Section 13 and 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.10.0.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Schedule Of Cash Flow Supplemental [Line Items]      
Cash paid for interest $ 98,411 $ 99,232 $ 108,101
Cash paid for income taxes, net of refunds received 64,199 95,043 93,368
Noncash investing and financing activities:      
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] (5,728) 9,349 (29,471)
Theatre properties acquired under capital and finance leases 18,851 46,727 33,282
Investment in NCM – receipt of common units (see Note 6) 5,012 18,363 11,111
Dividends accrued on unvested restricted stock unit awards (624) $ (558) $ (554)
NCM      
Noncash investing and financing activities:      
Interest expense – NCM (see Note 3) $ (19,724)    
[1] Additions to theatre properties and equipment included in accounts payable as of December 31, 2017 and 2018 were $31,276 and $37,004, respectively.